Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
STAP2 encodes the substrate of breast tumor kinase, an Src-type non-receptor tyrosine kinase.
Showing 10 out of 102 products:
Human Polyclonal STAP2 Primary Antibody for IHC (p), IHC - ABIN268819
Minoguchi, Minoguchi, Aki, Joo, Yamamoto, Yumioka, Matsuda, Yoshimura: STAP-2/BKS, an adaptor/docking protein, modulates STAT3 activation in acute-phase response through its YXXQ motif. in The Journal of biological chemistry 2003
Show all 5 Pubmed References
Human Polyclonal STAP2 Primary Antibody for IHC, ELISA - ABIN184610
Ikeda, Miyasaka, Sekine, Mizushima, Muromoto, Nanbo, Yoshimura, Matsuda: STAP-2 is phosphorylated at tyrosine-250 by Brk and modulates Brk-mediated STAT3 activation. in Biochemical and biophysical research communications 2009
Show all 5 Pubmed References
Human Polyclonal STAP2 Primary Antibody for EIA, IHC (p) - ABIN615870
Sekine, Ikeda, Tsuji, Yamamoto, Muromoto, Nanbo, Oritani, Yoshimura, Matsuda: Signal-transducing adaptor protein-2 regulates stromal cell-derived factor-1 alpha-induced chemotaxis in T cells. in Journal of immunology (Baltimore, Md. : 1950) 2009
Show all 2 Pubmed References
Human Polyclonal STAP2 Primary Antibody for WB - ABIN2477661
Mitchell, Sara, Crompton: A novel adaptor-like protein which is a substrate for the non-receptor tyrosine kinase, BRK. in Oncogene 2000
These findings indicate an essential role for STAP2 in the generation of a high-quality memory CD8 (show CD8A Antibodies)+ CTLs periphery, and suggest the therapeutic potential of STAP2 in cancer patients.
High STAP2 expression is associated with prostate cancer.
The Pyk2 (show PTK2B Antibodies)/STAP-2 interaction is a novel mechanism to regulate SDF-1alpha-dependent T-cell chemotaxis.
STAP2 is upregulated in uterosacral ligaments in pelvic organ prolapse
Our results demonstrate a critical contribution of STAP-2 in BCR-ABL (show ABL1 Antibodies) activity.
STAP-2 is a novel participant in the regulation of T cell apoptosis after stimulation
Interactions of STAP-2 with Brk (show PTK6 Antibodies) and STAT3 (show STAT3 Antibodies) participate in cell growth of human breast cancer cells.
STAP-2 expression in Jurkat T cells affects migration following stromal cell-derived factor-1alpha (SDF-1alpha) treatment; STAP-2 association with Vav1, the guanine-nucleotide exchanging factor for Rac1, enhances downstream Vav1/Rac1 signaling.
These data indicate that STAP-2/BKS negatively controls the FcepsilonRI (show FCER1G Antibodies)-mediated calcium mobilization and degranulation by direct modulation of tyrosine phosphorylation of PLC (show HSPG2 Antibodies)-gamma.
STAP-2/BKS is a modulator of STAT5 (show STAT5A Antibodies)-mediated signaling
results demonstrate a contribution of CCR7 (show CCR7 Antibodies) to STAP-2-dependent enhancement of BCR-ABL (show ABL1 Antibodies)-mediated cell growth in Ba/F3 cells
signal transducing adaptor protein 2 (STAP-2) is involved in cell migration, proliferation, and melanogenesis as well as chemokine receptor expression and tumorigenesis in B16F10 melanoma cells
STAP-2 has a potential to regulate plural molecular events during pathological inflammatory responses.
Signal-transducing adaptor protein-2 controls the IgE-mediated, mast cell-mediated anaphylactic responses.
STAP-2 directly binds to c-Fms (show CSF1R Antibodies) and interferes with the PI3K signaling, which leads to macrophage motility, in Raw 264.7 cells
STAP-2 associates with FAK (show PTK2 Antibodies) and enhances its degradation, proteasome inhibitors block FAK (show PTK2 Antibodies) degradation, and STAP-2 recruits an endogenous E3 ubiquitin ligase (show MUL1 Antibodies), Cbl (show CBL Antibodies), to FAK (show PTK2 Antibodies).
This gene encodes the substrate of breast tumor kinase, an Src-type non-receptor tyrosine kinase. The encoded protein possesses domains and several tyrosine phosphorylation sites characteristic of adaptor proteins that mediate the interactions linking proteins involved in signal transduction pathways. Alternative splicing results in multiple transcript variants.
signal-transducing adaptor protein 2
, BRK substrate
, breast tumor kinase substrate
, brk kinase substrate
, signal-transducing adaptor protein-2